We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
27 July 2015
VISCHER assisted Memo Therapeutics, a Basel/Zurich based spin-off company from the ETH Zurich, developing a disruptive platform technology for antibody discovery. This technology allows for the first time banking and mining the complete antibody repertoire of human and animal species by using nanoliter reactor technology thereby increasing throughput and performance of biological assays. The CHF 2.3 million financing round was led by Redalpine and other Swiss investors, including EVA Basel and Zürcher Kantonalbank. The team at VISCHER was led by Matthias Staehelin (Partner) with Moritz Jäggy (Associate), both Corporate.
Categories: Corporate and commercial, Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law
Attorney at Law and Civil Law Notary (BS/BL)
Alex Frei, footballer, coach and record goalscorer for the Swiss national team, has acquired a stake...
Evorest AG is a fintech start-up that specializes in the digital management of rental deposits. As a...
SWIMRUN AG, the organizer of major swimrun events, has acquired a majority stake in Swimrun USA...